| HOPE FOR FIBROIDS | ||||||||||||||||||||||
|
Media Channel 10 News October 10, 2005 Dr. Kirsch - UAE
|
By: Hope Waltman Author's Note: This article is compiled of facts and figures found through my personal research and an interview with Dr. Robert L. Worthington-Kirsch. Uterine
fibroids are benign tumors of the uterus. They are not cancers, but can
cause symptoms such as discomfort during sexual relations, interfere with
fertility, cause excessive bleeding during or between periods, and pressure
on the bladder or rectum. Uterine
fibroids can compromise fertility in a variety of ways. Some can
compress the fallopian tubes, preventing eggs from successfully traveling
from the ovaries to the uterus.
Some uterine fibroids change the shape of the uterus and act almost like an
IUD, causing miscarriages to occur.
Premature labor can happen because of the location and size of the
uterine fibroids. In some cases, uterine fibroids have been known to
grow during pregnancy, due to an increase in estrogen levels, and displace
the placenta or cause indentation/bulging into the uterine cavity that can
impede the growth of the baby. Fibroids may also have other, less
understood, negative effects on conception and pregnancy. Most women who
have uterine fibroids have no problems during pregnancy. Unless the woman or her doctor
identify something unusual, the standard medical prenatal care is usually
followed for a pregnant woman who has uterine fibroids. When
uterine fibroids cause problems with fertility, a woman should talk with her
doctor to see if the fibroids should be treated. The current
surgical therapy for fibroids in women who want to preserve their fertility
is myomectomy (surgical removal of the fibroids). This is usually a
major abdominal surgery, involving several weeks for recovery and a several
month wait after surgery before pregnancy can be attempted. Myomectomy has
good results as a fertility procedure in women with one or two easily
removed fibroids. However, its outcome is frequently worse for women
who have multiple fibroids or whose fibroids are in locations that make them
difficult to approach during surgery. In some of these women the risk
of having the myomectomy converted to hysterectomy (removal of the uterus)
can be unacceptably high. In addition, fibroids often regrow after
myomectomy. Within five years of myomectomy, as many as 50 percent of
women will have return of symptoms from regrowth of fibroids. In women
for whom myomectomy carries a high risk of complication (such as conversion
to hysterectomy) or who seek for a more durable treatment for their fibroid
symptoms Uterine Artery Embolization (UAE) may be an option. UAE is a
procedure where an Interventional Radiologist maneuvers a catheter into the
main artery supplying the uterus and injects small plastic particles to plug
up the blood vessels that supply the fibroids. The procedure cuts off
the blood supply to the fibroids, the fibroids infarct, and the uterus and
fibroids reduce in size. The
uterus is supplied with multiple blood vessels and the embolization does not
damage the remainder of the uterus. The use of
embolization to control uterine fibroids and excessive bleeding has been
used since at least the late 1970s.
UAE was first used as a treatment for fibroids in France in the late
80’s or early 90’s and the first report was published in Lancet in 1995. This is part one of a two-part set of articles on Pregnancy and Uterine Fibroid Disease. Watch for part two in the October issue of Today's Woman, where Dr. Worthington-Kirsch will answer questions concerning Uterine Artery Embolization and fertility. Coming in late September, www.hopeforfibroids.org, Hope Waltman, Founder, (e-mail) hopewaltman@paonline.com. Dr. Kirsch is the Medical Advisor for this web site. For more information on uterine fibroid treatments refer to www.fibroidcorner.com or contact Robert L. Worthington-Kirsch, MD, FSCVIR, Image Guided Surgery Associates, PC, e-mail kirsch@igsapc.com. Copyright: Today's Woman September 2002 Issue,
Lancaster, Pennsylvania. |
|
||||||||||||||||||||
Sources |
Site Map |
|
Last modified: Tuesday November 11, 2008 | |